Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DX25F6XRD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $8,623
Award facts
- Contract value 100% obligated
- $8,622.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,622.72 on August 20, 2025, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA) through the Medical Supply Chain division and is scheduled for completion by August 21, 2025, with performance taking place at the contractor's Park Ridge, Illinois location. The award carries no set-aside designation, allowing the contractor to compete on an open basis despite its woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA valued at approximately $500 million and extending through November 2026. The broader IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. Xtandi, an oncology treatment, represents one of many specialized pharmaceutical products the contractor regularly supplies to military medical installations as part of its established role in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DX25F6XRD?
SPE2DX25F6XRD was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 20, 2025.
How much is contract SPE2DX25F6XRD worth?
The government has obligated $8,623 on SPE2DX25F6XRD.
Is contract SPE2DX25F6XRD an order under another contract?
Yes. SPE2DX25F6XRD is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRD competed?
The extent of competition for SPE2DX25F6XRD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award